57 results · 36ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

TWO-LUMEN CENTRAL VENOUS ACCESS KIT WITH HEMOSTASIS VALVE/SIDE PORT

FDA 510(k)
FDA Class 2 ·Cardiovascular

ARROWg+ard Blue(R) MAC(TM) Two-Lumen Central Venous Access Kit for use with 7.5 - 8 Fr. Catheters The MAC(TM) Multi-Lumen Central Venous Access Device with ARROWg+ard Blue(R) permits venous access and catheter introduction to the central circulation. It may be inserted into the jugular, subclavian, or femoral veins. The ARROWg+ard(R) technology is intended to help provide protection against catheter-related infections. Clinical data have not been collected that demonstrate the use of the ARROWg+ard(R) antimicrobial surface in decreasing catheter-related infections for this device. It is not intended to be used as a treatment for existing infections, nor is it indicated for long-term use.

FDA Enforcement
Class II ·Terminated·Arrow International Inc·June 14, 2017

MAC(TM) Two-Lumen Central Venous Access Kit with ARROWg+ard Blue(R) Access Device, Integral Hemostasis Valve, Sharps Safety Features and Maximal Barrier Precautions for use with 7.5 - 8 Fr. Catheters The MAC(TM) Multi-Lumen Central Venous Access Device with ARROWg+ard Blue(R) permits venous access and catheter introduction to the central circulation. It may be inserted into the jugular, subclavian, or femoral veins. The ARROWg+ard(R) technology is intended to help provide protection against catheter-related infections. Clinical data have not been collected that demonstrate the use of the ARROWg+ard(R) antimicrobial surface in decreasing catheter-related infections for this device. It is not intended to be used as a treatment for existing infections, nor is it indicated for long-term use.

FDA Enforcement
Class II ·Terminated·Arrow International Inc·June 14, 2017

Henry Schein

FDA UDI
HENRY SCHEIN, INC.·00304040044704·Rongeur 5

RMO

FDA UDI
Rmo, Inc.·00885797099747·LING RETNR BD 3X3 6 CS WO/INST

Natus

FDA UDI
XLTEK·00382830020831·P32-STIM POD 1 (E-H)-10' (CR)

Metal Custom Rx

FDA UDI
AMERICAN ORTHODONTICS CORPORATION·00190746103513·BRACKET NARROW TWIN LEFT LATERAL 018 TQ=+14 A=+...

Merit Medical®

FDA UDI
Merit Medical Systems, Inc.·00884450136850·

Kyocera Medical Technologies, Inc.

FDA UDI
KYOCERA MEDICAL TECHNOLOGIES, INC.·00841523148806·Straight Implant Trial 25mm x 9mm x 7mm

MICROPERFORATION INSTRUMENT

FDA 510(k)
FDA Class 1 ·Orthopedic

CAVERMAP SURGICAL AID

FDA 510(k)
FDA Class 2 ·Ear, Nose, Throat

SYNCHRO GUIDEWIRE

FDA Adverse Event
Malfunction ·NEUROVASCULAR DIVISION, BOSTON SCIENTIFIC CORPORATION·Product code DQX·July 9, 2009

SYNCHRO GUIDEWIRE

FDA Adverse Event
Malfunction ·NEUROVASCULAR DIVISION, BOSTON SCIENTIFIC CORPORATION·Product code DQX·July 9, 2009

SYNCHRO GUIDEWIRE

FDA Adverse Event
Malfunction ·NEUROVASCULAR DIVISION, BOSTON SCIENTIFIC CORP.·Product code DQX·September 4, 2009

SYNCHRO GUIDEWIRE

FDA Adverse Event
Malfunction ·NEUROVASCULAR DIVISION, BOSTON SCIENTIFIC CORP.·Product code DQX·September 4, 2009

SYNCHRO 14 NEURO GUIDEWIRE

FDA Adverse Event
Injury ·NEUROVASCULAR, A DIVISION OF BOSTON SCIENTIFIC CORPORATION·Product code DQX·July 24, 2007

SYNCHRO GUIDEWIRE

FDA Adverse Event
Malfunction ·NEUROVASCULAR DIVISION, BOSTON SCIENTIFIC CORPORATION·Product code DQX·August 18, 2009

SYNCHRO -10 NEURO GUIDEWIRE

FDA Adverse Event
Malfunction ·BOSTON SCIENTIFIC CORP., NEUROVASCULAR DIV·Product code DQX·December 15, 2006

SYNCHRO-14 NEURO GUIDEWIRE

FDA Adverse Event
Malfunction ·NEUROVASCULAR , A DIV. OF BOSTON SCIENTIFIC CORP·Product code DQX·December 19, 2006

SYNCHRO 14 GUIDEWIRE

FDA Adverse Event
Injury ·BOSTON SCIENTIFIC CORP.·Product code DQX·September 20, 2007